Clinical Trials Directory

Trials / Unknown

UnknownNCT05791006

Neuropsychology of Financial Capacity

Status
Unknown
Phase
Study type
Observational
Enrollment
99 (estimated)
Sponsor
Istituto Auxologico Italiano · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

The present project aims to investigate the financial capacity in patients diagnosed with Parkinson's Disease or parkinsonism, brain tumor (glioma or meningioma) and cerebrovascular lesion (stroke), in order to evaluate the presence and degree of impairment, and the role of some factors as potential predictors of financial incapacity. The term 'financial capacity' means both operations relating, for example, to asset management or investing money, and activities of daily life such as shopping or using small sums of money; these activities are mediated by different cognitive functions, from numerical and arithmetic skills to decision making. Financial capacity is, in fact, an instrumental activity of daily life (i.e. Instrumental Activity Of Daily Living, I-ADL) whose impairment negatively affects the functional autonomy of the individual, so as to be subject to legal protection. To assess financial capacity, the Numerical Activities of Daily Living - Financial (NADL-F; Arcara et al., 2017) will be administered, a battery of tests aimed at investigating both financial performance and financial competence according to the most recent neuropsychological models proposed in the literature.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNeuropsychological testsNeuropsychological assessment with: * NADL-F * Frontal Assessment Battery (FAB) * functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) * Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients * Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients

Timeline

Start date
2021-08-04
Primary completion
2024-11-30
Completion
2024-11-30
First posted
2023-03-30
Last updated
2023-03-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05791006. Inclusion in this directory is not an endorsement.